Tachykinins / (notice n° 18763)
| 000 -LEADER | |
|---|---|
| fixed length control field | 01509nam a2200253 4500 |
| 001 - CONTROL NUMBER | |
| control field | UNI0000318 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20161124110503.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120418s2004 XX eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3540206906 (hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783540206903 (hardcover) |
| 040 ## - CATALOGING SOURCE | |
| Modifying agency | IMIST |
| Description conventions | AFNOR |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DCLC |
| 041 1# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1 |
| 245 #0 - TITLE STATEMENT | |
| Title | Tachykinins / |
| Statement of responsibility, etc | Peter Holzer. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | [Berlin] |
| Name of publisher, distributor, etc | Springer |
| Date of publication, distribution, etc | 2004. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 569 p. ; |
| Dimensions | 24 cm. |
| 490 1# - SERIES STATEMENT | |
| Series statement | Handbook of experimental pharmacology. |
| 500 ## - GENERAL NOTE | |
| General note | The tachykinins represent one of the most thoroughly investigated family of neuropeptides, whose members and receptors have been characterized at the genetic and molecular level and whose pharmacology has now been advanced to the first clinical application. These exciting accomplishments and prospects are reviewed and discussed in this volume in an authoritative manner. Particular emphasis is laid on the development of selective non-peptide antagonists for all 3 tachykinin receptors and their potential as novel drugs in a variety of diseases. The approval of the first tachykinin receptor antagonist as an antiemetic drug is particularly highlighted, and the utility of tachykinin receptor antagonists in affective disorders, chronic obstructive airway disease and irritable bowel syndrome, to name a few indications, is extensively considered. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Tachykinins |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Tachykinins--Physiological effect |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Holzer,, Peter. |
| Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 10870 | 615.1 HOL | 0000000016134 | 11/24/2016 | 11/24/2016 | Livre |
